Actavis was a generics giant whose rise mirrors the huge growth of off-patent medicines, while Gilead has rocketed into pharma's top 20 biggest companies in 2014 thanks to ground and record ...

This comes nine years after the company made bold moves overseas as it acquired Actavis’ UK and Actavis Ireland businesses from Teva Pharmaceutical Industries Ltd for around $769 million. VCCircle ...

The pharma companies made drugs that could help patients and spent lots of time telling doctors which drugs to give to who. Then payers came along and started scrutinising how much was being spent ...

Consolidated, Actavis Group's business in Romania (including production, distribution, parent company product sales and exports of cancer treatment drugs) attained 122 million euros last year.

Companies that have grown profits and net profit margins over the past 12 months ...

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

Earlier in his career, he held positions at pharmaceutical companies including Actavis PLC (now AbbVie, Inc. (ABBV)), the US subsidiary of Swiss company Nycomed Pharma S.A., which has since been ...

recently found pharmaceutical company AbbVie Healthcare India Private Ltd, a subsidiary of the U.S.-based AbbVie Inc,. guilty of sponsoring international trips to the tune of nearly ₹1.91 crore ...

Big Pharma will hunt for more acquisitions in 2025 as industry giants face patent expiration for some of their best-selling drugs, according to a top M&A banker. Merck's cancer drug Keytruda, the ...

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...